Head and Neck Surgery
M-A: Advanced computed tomographic localization techniques for primary hyperparathyroidism.
6 Apr, 2022 | 09:57h | UTCAdvanced Computed Tomographic Localization Techniques for Primary Hyperparathyroidism: A Systematic Review and Meta-analysis – JAMA Otolaryngology-Head & Neck Surgery (link to abstract – $ for full-text)
Podcast: Deep dive into deep neck infections in children.
31 Mar, 2022 | 07:57h | UTC#47: Deep Dive into Deep Neck Infections with Dr. Travis Crook – The Cribsiders
SEOM-TTCC clinical guideline in nasopharynx cancer.
25 Mar, 2022 | 08:20h | UTCSEOM-TTCC clinical guideline in nasopharynx cancer (2021) – Clinical and Translational Oncology
Consensus Statement | Minimally-invasive treatments for benign thyroid nodules: recommendations for information to patients and referring physicians.
24 Mar, 2022 | 08:42h | UTC
Position Paper | Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy.
24 Mar, 2022 | 08:34h | UTC
RCT: Elective upper-neck vs. whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma.
9 Mar, 2022 | 08:17h | UTCElective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)
Commentaries:
Elective Upper-Neck vs Whole-Neck Irradiation in Nasopharyngeal Carcinoma – The ASCO Post
Lower Neck-Sparing RT Succeeds in Nasopharyngeal Carcinoma— Phase III trial also shows that upper-neck irradiation leads to fewer late toxicities – MedPage Today (link to abstract – $ for full-text)
RCT: In operated patients with head and neck cancer, chemoradiotherapy with weekly cisplatin is noninferior to 3-weekly cisplatin and is associated with reduced toxicity.
3 Mar, 2022 | 08:11h | UTC
Commentary from the author on Twitter
Dear friends,
Finally, the results of JCOG1008, post operative CRT (weekly CDDP vs. 3-weekly CDDP) has published on Journal of Oncology.
Weekly CDDP+RT is a new treatment option with equal efficacy and better safety profile.
Please check the manuscript!!https://t.co/XG6mkGeo4Y— Naomi Kiyota (@kiyota_naomi) March 1, 2022
HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management.
1 Mar, 2022 | 08:30h | UTCHPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management – Nature Reviews Clinical Oncology (if the link is paywalled, try this one)
Consensus Statement: Head and neck cancer survivorship.
16 Feb, 2022 | 08:49h | UTCRelated:
Head and Neck Cancer Survivorship Care Guideline
American Cancer Society Head and Neck Cancer Survivorship Care Guideline
ED management of the post-laryngectomy patient.
13 Feb, 2022 | 21:44h | UTCED Management of the Post-Laryngectomy Patient – emDocs
ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
11 Feb, 2022 | 08:23h | UTC
Systematic Review: Chemotherapy for the treatment of oral cavity and oropharyngeal cancer.
13 Jan, 2022 | 08:14h | UTCSummary: Chemotherapy for mouth and throat cancer – Cochrane Library
Choosing Wisely for Thyroid Conditions: Ten things clinicians and patients should question – “Do not order thyroid ultrasound for nodule detection in patients without thyroid anatomic anomalies on clinical examination”.
9 Nov, 2021 | 01:11h | UTCSee complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada
RCT: Prophylactic steroids prevent hypocalcemia and voice dysfunction in patients undergoing thyroidectomy.
15 Sep, 2021 | 08:44h | UTCUse of Prophylactic Steroids to Prevent Hypocalcemia and Voice Dysfunction in Patients Undergoing Thyroidectomy: A Randomized Clinical Trial – JAMA Otolaryngology – Head & Neck Surgery (link to abstract – $ for full-text)
Author interview: Prophylactic Steroids for Postthyroidectomy Hypocalcemia and Voice Dysfunction
Commentary: IV Steroid Before Thyroidectomy Prevents Complications — One dose of dexamethasone reduced hypocalcemia, voice issues – MedPage Today (free registration required)
Commentary on Twitter
This RCT with 192 patients found that pre-op dexamethasone resulted in a reduction in hypocalcemia at 24 hrs post-op by 24% and reduction in voice dysfunction at 24 hrs by 25%. Strong evidence in supporting a pre-op 8mg dose of dexamethasone @JAMAOto https://t.co/UIt18DXclN
— Jay Piccirillo, MD (@PiccirilloJay) September 5, 2021
ASCO Guideline: Salivary gland hypofunction and/or xerostomia induced by nonsurgical cancer therapies.
19 Aug, 2021 | 08:50h | UTC
Review: Initial management of blunt and penetrating neck trauma.
17 Aug, 2021 | 08:40h | UTCInitial management of blunt and penetrating neck trauma – BJA Education
Clinical Picture: Mucormycosis after COVID-19 in a patient with diabetes.
6 Aug, 2021 | 10:09h | UTCMucormycosis after COVID-19 in a patient with diabetes – The Lancet
Related:
COVID-19 and mucormycosis superinfection: the perfect storm.
What is mucormycosis, the fungal infection affecting COVID patients in India?
[Preprint] The Emergence of COVID-19 Associated Mucormycosis: Analysis of Cases From 18 Countries.
Mucormycosis: The ‘black fungus’ maiming Covid patients in India
Global Guideline for the Diagnosis and Management of Mucormycosis
Global burden of cancer attributable to alcohol consumption – “Globally, an estimated 741.300, or 4·1% of all new cases of cancer in 2020 were attributable to alcohol consumption”.
14 Jul, 2021 | 11:07h | UTCNews release: Alcohol consumption linked to more than 740,000 new cancer cases in 2020 – The Lancet
Commentaries: Alcohol caused 740,000 cancer cases globally last year – study – The Guardian AND Expert reaction to study of alcohol and cancer – Science Media Centre
M-A: Direct comparison of preoperative imaging modalities for localization of primary hyperparathyroidism – “choline PET-CT would be the best preoperative imaging modality for localization of primary hyperparathyroidism”.
6 Jun, 2021 | 23:40h | UTCJAMA Otolaryngology – Head & Neck Surgery (free for a limited period)
Invited commentary: Localization Studies for Parathyroid Surgery (free for a limited period)
ASCO Guideline: Management of Salivary Gland Malignancy
28 Apr, 2021 | 08:13h | UTCManagement of Salivary Gland Malignancy: ASCO Guideline – Journal of Clinical Oncology
Survey: Despite guideline recommendations, many patients with low-risk thyroid cancer continue to be treated with suppressive doses of thyroid hormone
23 Apr, 2021 | 08:13h | UTCTSH Suppression for Papillary Thyroid Cancer: A Physician Survey Study – Thyroid (link to abstract – $ for full-text)
Commentary on Twitter
Hot off the press. We found that many patients with low-risk thyroid cancer continue to be treated with suppressive doses of thyroid hormone, emphasizing the need for more research to better guide thyroid cancer management. @AmThyroidAssn @UMRogelCancer https://t.co/iU3ObzQxBQ
— Maria Papaleontiou, MD (@MariaPapaleont1) March 30, 2021
RCT: Atenolol has similar efficacy as propranolol with fewer adverse events in the treatment of problematic infantile hemangiomas
20 Apr, 2021 | 05:32h | UTCEfficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial – JAMA Otolaryngology-Head & Neck Surgery (link to abstract – $ for full-text)
Guidelines for Management of Patients with Anaplastic Thyroid Cancer
20 Apr, 2021 | 05:24h | UTCCommentary: ATA Issues Guidelines for Managing Anaplastic Thyroid Cancer – HealthDay
M-A: Chemotherapy and radiotherapy in locally advanced head and neck cancer
15 Apr, 2021 | 06:29h | UTC
Commentary on Twitter
What is the best treatment in locally advanced HN Cancer?
Our latest individual patient data network meta-analysis available here for free @TheLancetOncol: https://t.co/UuFvjpKO6I
Many limitations but by far the largest work on the topic (115 RCT, 29000 pts).
#radonc #hncsm pic.twitter.com/eNYHbxsB4Q
— Pierre Blanchard, MD (@PBlanchardMD) April 14, 2021
Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery
23 Mar, 2021 | 02:33h | UTCSARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery – Anaesthesia
Commentary on Twitter
Our research has underpinned key recommendations in new guidance on SARS-CoV-2 infection & elective surgery from @Assoc_Anaes & @RCoANews & @RCSnews.
This guideline can act as a template for policy makers in other countries!
?https://t.co/kKgJXFf0vd pic.twitter.com/mJRasJTJws
— COVIDSurg (@CovidSurg) March 20, 2021